Current Trends in Drug Abuse Research 10th Annual Symposium
April 11, 2012 9:00 am - 4:00 pm
The Fenway Center
presented by The Center for Drug Discovery at Northeastern University

8:30am - 9.00am
Continental Breakfast

9:00am - 9:05am
Welcoming Remarks
Alexandros Makriyannis, Ph.D., Northeastern University

9:05am - 10:00am
STARS and SRF: Novel Targets for Insulin Resistance and Diabetes Pathophysiology
Mary-Elizabeth Patti, M.D., Joslin Diabetes Center and Harvard Medical School

10:00am - 10:30am
Synthesis and Biological evaluation of N-Acetylethanolamine Hydrolyzing Acid Amidase Inhibitors
Kyle Whitten, Northeastern University

10:30am - 10:45am
Coffee Break

10:45am - 11:15am
Behavioral Effects of Cannabinoid-1 Receptor (CB1) Neutral Antagonists
Jack Bergman, Ph.D., McLean Hospital, Harvard Medical School

11:15am - 12:00pm
Keynote Presentation
G Protein-coupled Receptor Heteromers as Novel Tharapeutic Targets
Lakshmi A. Devi, Ph.D., Mt. Sinai School of Medicine

12:00pm - 1:30pm
Lunch Break

1:30pm - 2:30pm
Keynote Presentation
Medication Development for Substance Abuse Disorders at NIDA
Jane B. Acri, Ph.D., National Institute on Drug Abuse, NIH

2:30pm - 3:00pm
A Novel Approach for Detecting Elevated Monoacylglycerol Lipase (MGL) Levels in a Complex Proteome
Mahmoud Nasar, Northeastern University

3:00pm - 3:15pm
Coffee Break

3:15pm - 3:45pm
Development of CB2 Selective Agonists for Treatment of Pain and Inflammation
Anu Mahadevan, Ph.D., Organix, Inc.

3:45pm - 4:00pm
Closing Remarks
Alexandros Makriyannis, Ph.D., Northeastern University

Program may be altered without prior notification.